Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Atorvastatin for Lithium-Induced NDI
NCT02967653Phase 2Completed
- Sponsor
- Lady Davis Institute for Medical Research
- Start
- Jul 2017
- Primary completion
- Jul 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in nephrogenic diabetes insipidus (NDI) comparing Atorvastatin with Placebo (2 arms). Primary endpoint: Raw Urine Osmolality value adjusted for baseline at 12 weeks. Started Jul 2017; status: completed.
02
Drugs
atorvastatin
03
Conditions
nephrogenic diabetes insipidus (NDI)
Beyond the preview
Go deeper on NCT02967653.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02967653.